Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2005 Mar 10;102(12):4488–4493. doi: 10.1073/pnas.0409850102

The interaction between σ70 and the β-flap of Escherichia coli RNA polymerase inhibits extension of nascent RNA during early elongation

Bryce E Nickels *,, Sean J Garrity *,, Vladimir Mekler , Leonid Minakhin §, Konstantin Severinov §, Richard H Ebright , Ann Hochschild *,
PMCID: PMC555512  PMID: 15761057

Abstract

The σ-subunit of bacterial RNA polymerase (RNAP) is required for promoter-specific transcription initiation. This function depends on specific intersubunit interactions that occur when σ associates with the RNAP core enzyme to form RNAP holoenzyme. Among these interactions, that between conserved region 4 of σ and the flap domain of the RNAP β-subunit (β-flap) is critical for recognition of the major class of bacterial promoters. Here, we describe the isolation of amino acid substitutions in region 4 of Escherichia coli σ70 that have specific effects on the σ70 region 4/β-flap interaction, either weakening or strengthening it. Using these σ70 mutants, we demonstrate that the σ region 4/β-flap interaction also can affect events occurring downstream of transcription initiation during early elongation. Specifically, our results provide support for a structure-based proposal that, when bound to the β-flap, σ region 4 presents a barrier to the extension of the nascent RNA as it emerges from the RNA exit channel. Our findings support the view that the transition from initiation to elongation involves a staged disruption of σ-core interactions.

Keywords: transcription, promoter escape, σ region 4, bacteriophage λ, PR′


The bacterial RNA polymerase (RNAP) holoenzyme consists of a catalytic core enzyme (α2ββ′ω) complexed with a σ factor. σ factors confer on the holoenzyme the ability to initiate promoter-specific transcription (1). The primary σ factor in Escherichia coli is σ70, and a typical σ70-dependent promoter bears two conserved sequence elements, the –10 and the –35 hexamers, that are separated by a spacer of ≈17 bp (1). All primary σ factors share four regions of conserved sequence (regions 1–4) (2). Regions 2, 3, and 4 contain DNA-binding domains responsible for recognition of the promoter –10 element, extended –10 element (3), and –35 element, respectively (1, 4). Regions 3 and 4 are separated by a flexible linker (region 3.2) (5, 6). σ70 ordinarily recognizes promoter sequences only in the context of the holoenzyme, formation of which depends critically on a high-affinity interaction between σ region 2 and a coiled-coil motif in the β′-subunit (7, 8). A weaker interaction between σ region 4 and the flap domain of the β-subunit (β-flap) is not required for holoenzyme formation, but is required to position σ region 4 for sequence-specific interaction with the promoter –35 element (9).

During the transition from initiation to elongation, the interaction between σ and the remainder of the elongation complex is weakened (1015). Structural evidence has led to the proposal that this is due, at least in part, to sequential displacement of portions of σ from the core enzyme by the newly synthesized RNA (5, 6, 16). Specifically, structures of RNAP holoenzyme (5, 6, 16) and structural models of the RNAP promoter open complex (16, 17) indicate that two regions of σ lie along the predicted path of the nascent RNA: (i) region 3.2, which is positioned within the RNA exit channel; and (ii) region 4, which, by virtue of its interaction with the β-flap, is positioned immediately adjacent to the end of the RNA exit channel. Thus, it has been proposed that, during early elongation, the nascent RNA (i) must displace σ region 3.2 from the RNA exit channel when the nascent RNA enters the channel (5, 16) [at a length of ≈10–11 nt (18)], and (ii) must displace σ region 4 from the β-flap when the nascent RNA emerges from the RNA exit channel (6) [at a length of ≈15–16 nt (19, 20)]. Analysis of early elongation complexes has provided evidence for displacement of σ region 3.2 from the RNA exit channel (21, 22), and possibly, for destabilization of the interaction between σ region 4 and the β-flap (23). However, evidence for the proposed RNA-mediated displacement of σ region 4 from the β-flap has not been reported.

Here, we describe the isolation and characterization of amino acid substitutions in region 4 of σ70 that alter the strength of the σ70 region 4/β-flap interaction. Using these substitutions, we show that the interaction between σ70 region 4 and the β-flap can inhibit extension of the nascent RNA when it reaches a length of 16 nt. The results provide evidence for the proposed requirement to displace σ region 4 from the β-flap when the nascent RNA emerges from the RNA exit channel, at a length of ≈15–16 nt. As such, the results provide support for the view that the transition from initiation to elongation involves a staged disruption of σ -core interactions (46, 16, 18, 24).

Materials and Methods

Expression Vectors and Strains. Plasmid pACλcI-β-flap encodes residues 1–236 of the bacteriophage λ cI protein fused to residues 858–946 of β under the control of the isopropyl-β-d-thiogalactoside (IPTG)-inducible lacUV5 promoter (9). Plasmids pBRα-σ70 and pBRα-σ70 D581G encode residues 1–248 of α fused to residues 528–613 of σ70 (with or without substitution D581G) under the control of tandem lpp and IPTG-inducible lacUV5 promoters (25, 26). Plasmid pBRα encodes wild-type α (27).

Strains KS1 (25) and BN317 (26) contain test promoters placOR2–62 and placCons–35C, respectively, linked to lacZ present in single copy on the chromosome (KS1) or an F′ episome (BN317).

β-Gal Assays. β-gal assays were performed as described (28), in duplicate on separate occasions. Values are the averages from one experiment; duplicate measurements differed by <5%.

Proteins. His-tagged versions of wild-type and mutant σ70 were purified as described (29) after overproduction from plasmid pLHN12-His. The E. coli RNAP core used in the assays shown in Figs. 4 and 5 was obtained from Epicentre Technologies (Madison, WI), and holoenzyme was made by incubation with a fivefold excess of σ70. Plasmid pIA325 (30) coexpressing E. coli RNAP core subunits α, β′ and His6-tagged βΔ900–909 was used to purify RNAP lacking the flap-tip helix (Δflap RNAP core) as described (31), except that a heparin purification step was omitted.

Fig. 4.

Fig. 4.

Effects of substitutions in σ70 region 4 on transcription in vitro. Single-round in vitro transcription assays were performed as described in Supporting Methods by using RNAP holoenzyme reconstituted with either wild-type σ70 or the indicated σ70 mutant and linear DNA templates bearing one of the three indicated promoters (Left) or galP1/cons (Right). (Left) The run-off transcription products (123, 120, and 100 nt for T7A2, lacUV5, and galP1/cons, respectively) that were internally labeled by using α-[32P]UTP. (Right) The abortive transcripts and the run-off transcripts (RO) that were end-labeled with γ-[32P]ATP.

Fig. 5.

Fig. 5.

Effects of substitutions in σ70 region 4 on early elongation pausing at λPR′. (A) A linear DNA template carrying λPR′ was used to perform single-round in vitro transcription assays as described in Supporting Methods with RNAP holoenzyme reconstituted with either wild-type σ70 or the indicated σ70 mutant. Aliquots of each transcription reaction were removed and stopped at the indicated times after the initiation of transcription. The transcripts were end-labeled with γ-[32P]ATP. The 16- and 17-nt RNA species (+16 and +17) and the 194-nt terminated transcript (T) are indicated. A complete gel image is shown in Fig. 8, which is published as supporting information on the PNAS web site. (B) Shown is the ratio of paused elongation complexes containing a 17-nt transcript to paused elongation complexes containing a 16-nt transcript (+17/+16 ratio) for each holoenzyme species. These values are the means of three independent experiments including that shown in A and were calculated by using the 1-min time point.

Fluorescence-Detected Electrophoretic Mobility-Shift Competition Experiments. Reaction mixtures contained (40 μl): 200 nM fluorescein-labeled σ derivative (σF; labeled at position 366; prepared as in ref. 32), 0–600 nM unlabeled competitor sigma (σX; prepared as in ref. 29), and 100 nM wild-type RNAP core (prepared as in ref. 32) or 100 nM Δflap RNAP core (see above), 40 mM Tris·HCl (pH 8.0), 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.2% Tween 20, and 5% glycerol. Reactions were initiated by addition of RNAP core and were allowed to proceed 12 h at 24°C. (Control reactions initiated by addition of σX yield equivalent results, indicating that the system reaches equilibrium.) Reaction mixtures were applied to 5% polyacrylamide slab gels, and electrophoresed in 90 mM Tris-borate, pH 8.0/0.2 mM EDTA (at 100 V for 90 min at room temperature). Fluorescence emission intensities were quantified by using an x/y fluorescence scanner (FluorImager 595, Molecular Dynamics). The fractional occupancy of RNAP core with σF (Θ) was calculated as described in Supporting Methods, which is published as supporting information on the PNAS web site.

Results

Substitutions in σ70 Region 4 That Weaken or Strengthen Its Interaction with the β-Flap. To investigate how the interaction between σ region 4 and the β-flap affects events that occur during the transition from initiation to elongation, we sought to identify amino acid substitutions in region 4 of σ70 that either weakened or strengthened the σ70 region 4/β-flap interaction. To accomplish this goal, we took advantage of a bacterial two-hybrid assay (27, 28) that enabled us to detect the interaction between a fragment of σ encompassing region 4 and a fragment of β encompassing the flap domain (9). In this two-hybrid assay, contact between a protein domain fused to a subunit of RNAP and a partner domain fused to a DNA-binding protein activates transcription from a test promoter bearing a recognition site for the DNA-binding protein. In this case, region 4 of σ70 (residues 528–613) was fused to the α-subunit N-terminal domain (NTD; replacing the α-subunit C-terminal domain), and the β-flap (residues 858–946) was fused to the cI protein of bacteriophage λ (Fig. 1A). Thus, we showed previously that the λcI-β-flap fusion protein activates transcription from test promoter placOR2–62 specifically in the presence of the α-σ70 chimera (9).

Fig. 1.

Fig. 1.

σ70 region 4 substitutions that weaken its interaction with the β-flap. (A) Bacterial two-hybrid assay. Cartoon depiction of how the interaction between σ70 region 4 (fused to the α-NTD) and the β-flap (fused to the bacteriophage λ cI protein) activates transcription from test promoter placOR2–62, which bears the λ operator OR2 centered 62 bp upstream of the start site of the lac core promoter. (B) Effects of substitutions in the σ moiety of the α-σ70 D581G chimera on transcription from placOR2–62 in the presence of the λcI-β-flap fusion protein. KS1 cells (see Materials and Methods) harboring compatible plasmids directing the synthesis of the indicated proteins were grown in the presence of different concentrations of IPTG and assayed for β-gal activity. (C) Schematic of test promoter placCons–35C. This promoter bears a consensus –35 element (TTGACA) upstream of the core promoter elements that serves as a binding site for the tethered σ70 region 4 moiety. (D) Effects of substitutions in the σ moiety of the α-σ70 D581G chimera on transcription from placCons–35C. BN317 cells (see Materials and Methods) harboring plasmids directing the synthesis of the indicated proteins were grown in the presence of different concentrations of IPTG and assayed for β-gal activity.

We first sought to identify amino acid substitutions in σ70 region 4 that weakened its interaction with the β-flap. To accomplish this goal, we introduced random mutations into the gene fragment encoding the σ moiety of the α-σ70 chimera and screened for mutations that specifically abolished the stimulatory effect of the λcI-β-flap fusion protein on transcription from test promoter placOR2–62 (see Supporting Methods). To identify mutations causing effects that were specific to the σ70 region 4/β-flap interaction, we took advantage of a genetic assay that we developed previously to detect the ability of σ region 4 to bind a –35 element (25, 26). In this assay, interaction between the σ moiety of the α-σ70 chimera and an ectopic –35 element positioned upstream of the core promoter elements activates transcription from test promoter placCons–35C (26) (Fig. 1C). To facilitate the genetic screen, we also took advantage of a previously isolated amino acid substitution, D581G (26), that evidently stabilizes the folded structure of the tethered σ70 region 4 moiety and thus facilitates detection of the interaction between σ70 region 4 and both the β-flap and the ectopic –35 element (9, 26). We therefore screened for amino acid substitutions that disrupted the interaction between the σ moiety of the α-σ70 D581G chimera and the β-flap (by using the assay depicted in Fig. 1 A), but did not disrupt the ability of the σ moiety to bind to a –35 element (by using the assay depicted in Fig. 1C).

Using these criteria, we identified several substitutions in the σ moiety of the α-σ70 D581G chimera that specifically disrupted the σ70 region 4/β-flap interaction (Fig. 1B and data not shown). For the purposes of performing functional studies, we selected two for further study. One substitution (L607P) completely abolished and the other substitution (R541C) nearly abolished the stimulatory effect of the λcI-β-flap fusion protein on transcription from placOR2–62 (Fig. 1B), but neither inhibited the ability of the tethered σ moiety to bind to the ectopic –35 element of placCons–35C (Fig. 1D). We also combined the two substitutions and found that the effects of the double substitution were similar to that of single-substitution L607P (Fig. 1 B and D).

Next, we sought to identify amino acid substitutions in σ70 region 4 that strengthened its interaction with the β-flap. Because the interaction between σ70 region 4 (without the D581G substitution) and the β-flap is just above the threshold of detection in our two-hybrid assay (9), we used the α-σ70 chimera containing wild-type σ70 region 4 for this screen. After introducing random mutations into the gene fragment encoding the σ moiety of the α-σ70 chimera, we screened for substitutions that increased the stimulatory effect of the λcI-β-flap fusion protein on transcription from placOR2–62. As anticipated, we identified substitution D581G; among others that we identified (see Supporting Methods) was substitution T544M. Fig. 2A shows that substitutions D581G and T544M increased transcription from placOR2–62 specifically in the presence of the λcI-β-flap fusion protein by factors of ≈3.5 and ≈2.5, respectively (compared with the level measured with the wild-type α-σ70 chimera).

Fig. 2.

Fig. 2.

Substitutions in σ70 region 4 that strengthen its interaction with the β-flap. (A) Effects of substitutions in the σ moiety of the α-σ70 chimera on transcription from placOR2–62 (depicted in Fig. 1 A) in the presence of the λcI-β-flap chimera. KS1 cells harboring compatible plasmids directing the synthesis of the indicated proteins were grown in the presence of different concentrations of IPTG and assayed for β-gal activity. (B) Effects of substitutions in the σ moiety of the α-σ70 D581G chimera on transcription from placCons–35C (depicted in Fig. 1C). BN317 cells harboring plasmids directing the synthesis of the indicated proteins were grown in the presence of different concentrations of IPTG and assayed for β-gal activity.

An alignment of σ factors (2) revealed that in addition to threonine and methionine, the hydrophobic residues isoleucine, leucine, and valine also occur at the position corresponding to T544 of σ70. We therefore tested the effect of introducing each of these hydrophobic residues (I, L, or V) at position 544 of the σ moiety of the α-σ70 chimera. Substitution T544L had the same effect as substitution T544M on the interaction between σ70 region 4 and the β-flap (data not shown), whereas substitutions T544I and T544V had stronger effects, increasing transcription from placOR2–62 in the presence of the λcI-β-flap fusion protein by a factor of ≈8 (Fig. 2 A and data not shown). Finally, when introduced into the σ moiety of the α-σ70 chimera in combination, substitutions D581G and T544I increased transcription from placOR2–62 in the presence of the λcI-β-flap fusion protein by a factor of ≈40 (Fig. 2 A).

As a control, we tested the effects of the substitutions at σ70 positions 581 and 544 on transcription from placCons–35C. As shown previously (26), substitution D581G in the tethered σ moiety permits detection of a protein/DNA interaction between the σ moiety and the ectopic –35 element of placCons–35C (Fig. 2B). In contrast, substitutions T544M and T544I did not have this effect (data not shown), and slightly reduced the ability of the tethered σ70 D581G moiety to interact with the ectopic –35 element (Fig. 2B). Taken together, these results suggest that substitutions T544I and T544M specifically increase the strength of the σ70 region 4/β-flap interaction.

Location of Amino Acid Substitutions in the Context of a Bacterial Holoenzyme Structure. Consistent with our observation that substitutions at positions R541, T544, and L607 specifically altered the σ70 region 4/β-flap interaction, examination of the structure of a bacterial holoenzyme (6) reveals that the residues corresponding to σ70 residues R541, T544, and L607 lie at the σ region 4/β-flap interface (Fig. 3), positioned for contact with residues of the β-flap-tip helix, the critical determinant for the binding of σ70 region 4 (33). On the other hand, the residue corresponding to σ70 residue D581 is not located at the σ region 4/β-flap interface (Fig. 3), which is consistent with our observation that effects of substitution D581G in σ70 are not limited to the interaction of σ70 region 4 with the β-flap (26).

Fig. 3.

Fig. 3.

Location of substitutions that alter the interaction between σ70 region 4 and the β-flap in the Thermus thermophilus holoenzyme crystal structure (6). The T. thermophilus primary σ-subunit (σA) is orange, the β-subunit is cyan, and the β′-subunit is pink. Shown is the interface between σ region 4 (σ4) and the β-flap-tip helix (cyan worm). The locations of residues in σA (351, 354, 391, and 418) that correspond to positions R541, T544, D581, and L607 of σ70, respectively, are red (substitutions that weaken the interaction) or blue (substitutions that strengthen the interaction).

Effects of σ70 Substitutions on Binding to RNAP Core in Vitro. We wished to determine whether amino acid substitutions identified in the two-hybrid assay would affect the σ70/β-flap interaction in the context of RNAP holoenzyme. Accordingly, we performed fluorescence-detected EMSAs to quantify the effects of these substitutions on the σ70/core interaction. We performed assays, in parallel, by using wild-type RNAP core and an RNAP core derivative lacking the β-flap-tip helix (30) (Δflap RNAP), to determine the specific effects of the substitutions on the σ70/β-flap interaction (Fig. 7, which is published as supporting information on the PNAS web site). Thus, we compared the abilities of unlabeled wild-type σ70 and mutant σ70 derivatives to displace fluorescein-labeled wild-type σ70 from either wild-type RNAP core or Δflap RNAP core, determining a set of relative equilibrium-binding constants (relative Kb values) for each RNAP core enzyme (Table 1, second and third columns). We then determined the ratios of the relative Kb values, thereby extracting the β-flap-dependent effects of the amino acid substitutions in σ70 region 4 (Table 1, last column). Assuming that the only relevant difference between the two core enzymes is the inability of the Δflap RNAP core to bind σ70 region 4, the results indicate that substitutions R541C, L607P, and the combination R541C/L607P weaken the σ70/β-flap interaction in the context of RNAP holoenzyme, and that substitutions T544M, T544I, and the combination T544I/D581G strengthen the σ70/β-flap interaction in the context of RNAP holoenzyme. In addition, the results establish a correlation between the relative effects of these substitutions in the two-hybrid assay in vivo and their relative effects in the competition assay in vitro.

Table 1. Relative equilibrium-binding constants.

Wild-type RNAP
Δflap RNAP
Ratio
σ70 Derivative Relative Kb Relative Kb Flap-specific relative Kb
R541C/L607P 0.46 ± 0.03 1.2 ± 0.2 0.38
L607P 0.52 ± 0.07 0.96 ± 0.09 0.54
R541C 1.0 ± 0.2 1.8 ± 0.2 0.56
Wild-type 1.0 1.0 1.0
T544M 2.8 ± 0.3 1.1 ± 0.1 2.5
T544I 5.9 ± 0.4 1.1 ± 0.1 5.4
T544I/D581G 12 ± 4 1.0 ± 0.1 12

Effects on Promoter Recognition. Next, we tested whether substitutions R541C and L607P would cause defects in the recognition of –10/–35 promoters. By using reconstituted holoenzymes (Eσ70 WT, Eσ70 R541C, etc.), we performed single-round run-off transcription assays with DNA templates bearing two different –10/–35 promoters: T7A2 and lacUV5. We found that, although Eσ70 R541C and Eσ70 L607P manifested either no defects (R541C) or modest defects (L607P) in the production of run-off transcripts from the –10/–35 promoters, Eσ70 R541C/L607P produced only ≈40% and 10% as many transcripts as Eσ70 WT from the T7A2 and lacUV5 promoters, respectively (Fig. 4). These results are consistent with the expectation that disrupting the σ70 region 4/β-flap interaction in the context of the holoenzyme would cause a defect in the recognition of –10/–35 promoters (9, 33).

We also examined the ability of the mutant holoenzymes to transcribe a DNA template bearing a promoter of the extended –10 class (galP1/cons); extended –10 promoters are defined by the presence of a TG dinucleotide 1 bp upstream of the –10 hexamer, and typically lack a recognizable –35 element. As shown in Fig. 4, the mutant holoenzymes manifested no defects in the production of run-off transcripts from galP1/cons. However, further inspection of the transcription products synthesized under the control of galP1/cons revealed a difference between the mutant holoenzymes and Eσ70 WT. As shown in Fig. 4 Right, several short RNA products (likely the result of abortive initiation, which occurs before promoter escape) are evident in the reaction performed with Eσ70 WT; one of these, identified as the 9-mer based on analysis with limiting sets of nucleotides (data not shown), is particularly prominent. Strikingly, this RNA product is selectively depleted in reactions performed with Eσ70 L607P (Fig. 4) or with Eσ70 R541C/L607P (data not shown). These findings suggest that the weakened σ70 region 4/β-flap interaction facilitates promoter escape at galP1/cons, raising the possibility that this effect (which results in a relative increase in the amount of run-off transcript) may mask a promoter-recognition defect at galP1/cons. To evaluate this possibility, we performed DNase I footprinting assays to compare the abilities of Eσ70 WT and Eσ70 L607P to bind galP1/cons; the mutant holoenzyme exhibited a moderate promoter-binding defect in this experiment (data not shown). These results suggest that the σ70 region 4/β-flap interaction can contribute to promoter binding, even in the absence of an identifiable –35 element (see Discussion).

Effects on Early Elongation Pausing. The interaction between σ region 4 and the β-flap positions region 4 immediately adjacent to the end of the RNA exit channel (5, 6, 16). Structure-based models predict steric clash between the nascent transcript and σ region 4 when the nascent RNA first emerges from the RNA exit channel (6) at a length of ≈15–16 nt (19, 20). It has therefore been proposed that σ region 4 must be dislodged from the β-flap to permit extension of the nascent RNA beyond this point (6). Predictions arising from this proposal are that weakening the σ70 region 4/β-flap interaction should facilitate extension of the nascent RNA beyond ≈15–16 nt, and conversely, that strengthening this interaction should inhibit extension of the nascent RNA beyond ≈15–16 nt. To test these predictions, we took advantage of an early elongation pause that occurs during transcription from the bacteriophage λ late promoter PR′ (34). At this promoter, RNAP holoenzyme pauses as a result of an interaction between region 2 of σ70 and a DNA sequence element in the initial transcribed region that resembles a promoter –10 element (35). The pause, which is strictly dependent on the presence of σ70 in elongating RNAP, is manifested in early elongation complexes containing a 16- or 17-nt transcript (34). In particular, a certain fraction of paused early elongation complexes at λPR′ contains a 16-nt transcript, and a certain fraction contains a 17-nt transcript.

We therefore sought to take advantage of the amino acid substitutions that we had isolated to ask whether altering the strength of the σ70 region 4/β-flap interaction would alter the proportion of paused early elongation complexes containing either a 16- or 17-nt nascent transcript. To address this question, we performed single-round in vitro transcription assays using Eσ70 WT, Eσ70 L607P, or Eσ70 T544I/D581G (Fig. 5A). When reactions were performed with Eσ70 WT, among the fraction of RNAP molecules that paused, the ratio of paused elongation complexes containing a 17-nt transcript to paused elongation complexes containing a 16-nt transcript (+17/+16 ratio) was 1.9 (± 0.2) (Fig. 5B). In contrast, when reactions were performed with Eσ70 L607P (a substitution that weakens the σ70 region 4/β-flap interaction), the +17/+16 ratio was 5.2 (± 0.7), and when reactions were performed with Eσ70 T544I/D581G (substitutions that strengthen the σ70 region 4/β-flap interaction), the +17/+16 ratio was 1.0 (± 0.1). We conclude from these results that weakening the σ70 region 4/β-flap interaction increases the probability that RNAP will add the 17th nt to the nascent RNA in the context of an early elongation complex at λPR′. Conversely, strengthening the σ70 region 4/β-flap interaction decreases the probability that RNAP will add the 17th nt to the nascent RNA.

Discussion

We report the isolation of amino acid substitutions in σ70 region 4 that specifically alter the strength of its interaction with the flap domain of the RNAP β-subunit. Characterization of RNAP holoenzymes containing the corresponding σ70 mutants reveals that altering the strength of the σ70 region 4/β-flap interaction affects not only transcription initiation but also transcription elongation.

σ70 Region 4-Flap Interaction in Transcription Initiation: Recognition of Extended10 Promoters. We found that weakening the interaction between σ70 region 4 and the β-flap resulted in defects in the utilization not only of –10/–35 promoters but also of a consensus extended –10 promoter (galP1/cons) (Fig. 4; see also Note 1 in Supporting Text, which is published as supporting information on the PNAS web site). Although galP1/cons lacks a recognizable –35 element, it has been shown previously that, in the RNAP-promoter open complex at galP1/cons, σ70 region 4 interacts with DNA in the –35 region (9, 36, 37). The σ70/β-flap interaction may help position σ70 region 4 for such nonspecific interaction with DNA in the –35 region. Alternatively, or in addition, the σ70/β-flap interaction may help position σ70 region 4 for possible interaction with the α-C-terminal domain (38, 39). One or both of these interactions could stabilize the binding of RNAP to the promoter and/or facilitate promoter melting (36).

A previous study (9) reported that an RNAP derivative lacking 30 residues of the β-flap is defective in transcription initiation from a –10/–35 promoter (T7A2), but not from galP1/cons. Possibly, the difference between this previous result and our finding here reflects a functional difference between the holoenzyme in which the β-flap has been deleted and holoenzymes in which the σ70 region 4/β-flap interaction has been destabilized by single or double amino acid substitutions. Another previous study (33) identified single amino acid substitutions in the β-flap-tip helix that preferentially inhibited promoter engagement at a –10/–35 promoter; however, smaller effects on promoter engagement at galP1/cons were not excluded.

We also found that weakening the σ70 region 4/β-flap interaction causes a selective loss of a prominent abortive RNA product that is synthesized at galP1/cons. It has been proposed that the clash between the nascent RNA and σ70 region 3.2 positioned in the RNA exit channel contributes to abortive initiation (5, 24); the extent of abortive initiation can also be influenced by promoter strength (40). Destabilization of the σ70 region 4/β-flap interaction could result in a reduction in abortive RNA products because σ70 region 3.2 may be more easily displaced from the RNA exit channel and/or because of the loss of sequence-nonspecific interactions between σ70 region 4 and DNA in the –35 region.

σ70 Region 4-Flap Interaction in Transcription Elongation: Extension of 16-nt Nascent RNA. We observed an inverse correlation between the relative strength of the σ70 region 4/β-flap interaction and the ability of RNAP holoenzyme to extend the nascent RNA past position 16 when σ70 region 2 is bound to the pause-inducing –10-like element at λPR′. In light of structural considerations, we propose that the effect of the σ70 region 4/β-flap interaction at λPR′ is the manifestation of steric clash between the nascent RNA and region 4 that occurs when the nascent RNA first emerges from the RNA exit channel, at a length of ≈15–16 nt (19, 20). In particular, we propose that the nascent RNA must displace region 4 of σ70 from the β-flap, or at least alter the interaction between region 4 and the β-flap, for elongation to proceed past 16 nt (Fig. 6). Thus, when the interaction between σ70 region 4 and the β-flap is weakened, extension past 16 nt is favored; and, when the interaction between σ70 region 4 and the β-flap is strengthened, extension past 16 nt is disfavored. We emphasize that at λPR′, the inferred steric clash between the nascent RNA and region 4 of σ70 manifests itself only as a redistribution of paused elongation complexes (see Supporting Text, Notes 2 and 3), but is not required for their formation (that depends strictly on the protein/DNA interaction of σ70 region 2 and the pause-inducing sequence element). In the case of λPR′, this clash evidently occurs at a nascent-RNA length of 16 nt, but the exact point of the clash might vary, depending on the sequence of the initial transcribed region; in addition, the clash might in some cases occur before promoter escape (40).

Fig. 6.

Fig. 6.

Extension of nascent RNA past 16 nt at λPR′ requires displacement of σ70 region 4 from the β-flap. Cartoons depict sequence of events during initiation and early elongation at λPR′. (Upper) The initiation complex. σ70 region 3.2 (σ3.2) is located within the RNA exit channel and σ70 region 4 (σ4) is bound to the β-flap. (Lower) The paused elongation complex with σ70 region 2(σ2) bound to the pause-inducing –10-like element. The nascent RNA, which is not shown, has displaced σ70 region 3.2 from the RNA exit channel. Enlargements depict proposed clash of the nascent RNA with σ4 bound to the β-flap that requires displacement of σ4 for addition of the 17th nt.

Staged Disruption of σ70/Core Interactions in Transition from Initiation to Elongation. Our finding that σ70 region 4 presents a barrier to the nascent RNA as it emerges from the RNA exit channel supports the view that the transition from initiation to elongation involves staged displacement of segments of σ70 from RNAP core (46, 16, 18, 24). According to this view, the nascent RNA displaces distinct segments of σ70 in distinct steps. In a first step, entry of the nascent RNA into the RNA exit channel, at a length of 10–11 nt, displaces σ70 region 3.2 from the RNA exit channel, and possibly, as a consequence, weakens the σ70 region 4/β-flap interaction. In a second step, emergence of the nascent RNA from the RNA exit channel, at a length of 15–16 nt, displaces σ70 region 4 from the β-flap, which may serve to prevent σ70 region 4 from making nonspecific interactions with the DNA that would impede the elongation process. Our findings provide support for the existence of the second step and suggest that displacement of σ70 region 4 from the β-flap is an obligatory step during formation of a mature elongation complex.

Supplementary Material

Supporting Information
pnas_102_12_4488__.html (1.6KB, html)

Acknowledgments

We thank S. Busby (University of Birmingham, Birmingham, U.K.), B. Gregory (Harvard Medical School), I. Artsimovitch (Ohio State University, Columbus), and B. Landick (Univeristy of Wisconsin, Madison) for providing reagents and E. (G. Unit) Schwartz for assistance with mutant screens. This work was supported by National Institutes of Health Grants GM44025 (to A.H.), GM41376 (to R.H.E.), and GM64530 (to K.S.) and by a Howard Hughes Medical Institute Investigatorship (to R.H.E.).

Author contributions: B.E.N., S.J.G., K.S., R.H.E., and A.H. designed research; B.E.N., S.J.G., V.M., and L.M. performed research; L.M. contributed new reagents/analytic tools; B.E.N., S.J.G., V.M., R.H.E., and A.H. analyzed data; and B.E.N., R.H.E., and A.H. wrote the paper.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: RNAP, RNA polymerase; IPTG, isopropyl-β-d-thiogalactoside; NTD; N-terminal domain.

References

  • 1.Gross, C. A., Chan, C., Dombroski, A., Gruber, T., Sharp, M., Tupy, J. & Young, B. (1998) Cold Spring Harbor Symp. Quant. Biol. 63, 141–155. [DOI] [PubMed] [Google Scholar]
  • 2.Lonetto, M., Gribskov, M. & Gross, C.A. (1992) J. Bacteriol. 174, 3843–3849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Barne, K. A., Bown, J. A., Busby, S.J. & Minchin, S. D. (1997) EMBO J. 16, 4034–4040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Murakami, K. S. & Darst, S. A. (2003) Curr. Opin. Struct. Biol. 13, 31–39. [DOI] [PubMed] [Google Scholar]
  • 5.Murakami, K. S., Masuda, S. & Darst, S. A. (2002) Science 296, 1280–1284. [DOI] [PubMed] [Google Scholar]
  • 6.Vassylyev, D. G., Sekine, S., Laptenko, O., Lee, J., Vassylyeva, M. N., Borukhov, S. & Yokoyama, S. (2002) Nature 417, 712–719. [DOI] [PubMed] [Google Scholar]
  • 7.Arthur, T. M. & Burgess, R. R. (1998) J. Biol. Chem. 273, 31381–31387. [DOI] [PubMed] [Google Scholar]
  • 8.Young, B. A., Gruber, T. M. & Gross C. A. (2004) Science 303, 1382–1384. [DOI] [PubMed] [Google Scholar]
  • 9.Kuznedelov, K., Minakhin, L., Niedziela-Majka, A., Dove, S.L., Rogulja, D., Nickels, B.E., Hochschild, A., Heyduk, T. & Severinov, K. (2002) Science 295, 855–857. [DOI] [PubMed] [Google Scholar]
  • 10.Carpousis, A. & Gralla, J. (1985) J. Mol. Biol. 183, 165–177. [DOI] [PubMed] [Google Scholar]
  • 11.Straney, D. & Crothers, D. (1987) J. Mol. Biol. 193, 267–278. [DOI] [PubMed] [Google Scholar]
  • 12.Krummel, B. & Chamberlin, M. J. (1989) Biochemistry 28, 7829–7842. [DOI] [PubMed] [Google Scholar]
  • 13.Metzger, W., Schickor, P., Meier, T., Werel, W. & Heumann, H. (1993) J. Mol. Biol. 232, 35–49. [DOI] [PubMed] [Google Scholar]
  • 14.Daube, S. & von Hippel, P. (1999) Proc. Natl. Acad. Sci. USA 96, 8390–8395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hansen, U. M. & McClure, W. R. (1980) J. Biol. Chem. 255, 9564–9570. [PubMed] [Google Scholar]
  • 16.Mekler, V., Kortkhonjia, E., Mukhopadhyay, J., Knight, J., Revyakin, A., Kapanidis, A. N., Niu, W., Ebright, Y. W., Levy, R. & Ebright, R. H. (2002) Cell 108, 599–614. [DOI] [PubMed] [Google Scholar]
  • 17.Murakami, K. S., Masuda, S., Campbell, E. A., Muzzin, O. & Darst, S. A. (2002) Science 296, 1285–1290. [DOI] [PubMed] [Google Scholar]
  • 18.Borukhov, S. & Nudler, E. (2003) Curr. Opin. Microbiol. 6, 93–100. [DOI] [PubMed] [Google Scholar]
  • 19.Korzheva, N., Mustaev, A., Kozlov, M., Malhotra, A., Nikiforov, V., Goldfarb, A. & Darst, S. A. (2000) Science 289, 619–625. [DOI] [PubMed] [Google Scholar]
  • 20.Komissarova, N. & Kashlev, M. (1998) Proc. Natl. Acad. Sci. USA 95, 14699–14704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Marr, M. T., Datwyler, S. A., Meares C. F. & Roberts, J. W. (2001) Proc. Natl. Acad. Sci. USA 98, 8972–8978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mukhopadhyay, J., Kapanidis, A. N., Mekler, V., Kortkhonjia, E., Ebright, Y. W. & Ebright, R. H. (2001) Cell 106, 453–463. [DOI] [PubMed] [Google Scholar]
  • 23.Nickels, B. E., Roberts, C. W., Sun, H., Roberts, J. W. & Hochschild, A. (2002) Mol. Cell 10, 611–622. [DOI] [PubMed] [Google Scholar]
  • 24.Young, B. A., Gruber, T. M. & Gross, C. A. (2002) Cell 109, 417–420. [DOI] [PubMed] [Google Scholar]
  • 25.Dove, S. L., Huang, F. W. & Hochschild, A. (2000) Proc. Natl. Acad. Sci. USA 97, 13215–13220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nickels, B. E., Dove, S. L., Murakami, K. S., Darst, S.A. & Hochschild, A. (2002) J. Mol. Biol. 324, 17–34. [DOI] [PubMed] [Google Scholar]
  • 27.Dove, S. L., Joung, J. K. & Hochschild, A. (1997) Nature 386, 627–630. [DOI] [PubMed] [Google Scholar]
  • 28.Dove, S. L. & Hochschild, A. (2004) Methods Mol. Biol. 261, 231–246. [DOI] [PubMed] [Google Scholar]
  • 29.Panaghie, G., Aiyar, S. E., Bobb, K. L., Hayward, R. S. & de Haseth, P. L. (2000) J. Mol. Biol. 299, 1217–1230. [DOI] [PubMed] [Google Scholar]
  • 30.Toulokhonov, I., Artsimovitch, I. & Landick, R. (2001) Science 292, 730–733. [DOI] [PubMed] [Google Scholar]
  • 31.Artsimovitch, I., Svetlov, V., Murakami, K. S. & Landick R. (2003) J. Biol. Chem. 278, 12344–12345. [DOI] [PubMed] [Google Scholar]
  • 32.Knight, J. L., Mekler, V., Mukhopadhyay, J., Ebright, R. H. & Levy, R. M. (2005) Biophys. J. 88, 925–928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Geszvain, K., Gruber, T. M., Mooney, R. A., Gross, C. A. & Landick, R. (2004) J. Mol. Biol. 343, 569–587. [DOI] [PubMed] [Google Scholar]
  • 34.Roberts, J. W., Yarnell, W., Bartlett, E., Guo, J., Marr, M., Ko, D. C., Sun, H. & Roberts, C. W. (1998) Cold Spring Harbor Symp. Quant. Biol. 63, 319–325. [DOI] [PubMed] [Google Scholar]
  • 35.Ring, B. Z., Yarnell, W. S. & Roberts, J. W. (1996) Cell 86, 485–493. [DOI] [PubMed] [Google Scholar]
  • 36.Minakhin, L. & Severinov, K. (2003) J. Biol. Chem. 278, 29710–29718. [DOI] [PubMed] [Google Scholar]
  • 37.Bown, J. A., Kolb, A., Meares, C. F., Ishihama, A., Minchin, S. D. & Busby, S. J. (2000) J Bacteriol. 182, 2982–2984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ross, W., Schneider, D. A., Paul, B. J., Mertens, A. & Gourse, R. L. (2003) Genes Dev. 17, 1293–1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Chen, H., Tang, H. & Ebright R. H. (2003) Mol. Cell 11, 1621–1633. [DOI] [PubMed] [Google Scholar]
  • 40.Vo, N. V., Hsu, L. M., Kane, C. M. & Chamberlin M. J. (2003) Biochemistry 42, 3798–3811. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
pnas_102_12_4488__.html (1.6KB, html)
pnas_102_12_4488__1.pdf (116.1KB, pdf)
pnas_102_12_4488__2.html (3.5KB, html)

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES